glp-1 nobel prize Lotte Bjerre Knudsen, 2025 Breakthrough in Life Sciences laureate from Novo Nordisk, shared her pioneering work on GLP-1, which led to the first medicines for diabetes and obesity and the first Scientists who discovered the Glucagon

Unlike small molecules with well-defined structures, peptides themselves are also prone to a wide range of peptide-related impurities that persist regardless of production process

After you click the "Get Started' button, simply scroll down to "Medical Weight Loss", and follow the steps

Approved in 2022 for type 2 diabetes, Mounjaro is in the same class as Ozempic

Plaintiffs who began treatment in 2017, 2018, or 2019 received medications without warnings about conditions now recognized as medication-related

If GLP-1 medications really do lower chronic inflammation, the benefits could extend far beyond weight loss